Gene-mediated therapy for BCG-unresponsive nonmuscle-invasive bladder cancer: mechanisms, clinical evidence, and practical implementation
Gene-mediated therapy is gradually advancing NMIBC care, with expanding indications and potent combinations positing itself to improve bladder preservation and long-term outcomes.
Authors
- Jeremy Yuen‐Chun Teoh (ORCID: https://orcid.org/0000-0002-9361-2342)
- David Leung (ORCID: https://orcid.org/0000-0002-2078-7934)
- Chris Ho-Ming Wong
- Paolo Gontero
Institutions
- Chinese University of Hong Kong (HK)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Chinese University of Hong Kong, Shenzhen (CN)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Current Opinion in Urology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1097/mou.0000000000001345
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02